Ingalls & Snyder LLC Novartis Ag Transaction History

Ingalls & Snyder LLC

  • $2.55 Billion
  • Q4 2024

A detailed history of Ingalls & Snyder LLC transactions in Novartis Ag stock. As of the latest transaction made, Ingalls & Snyder LLC holds 117,001 shares of NVS stock, worth $12.8 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares
117,001
Previous 116,434 0.49%
Holding current value
$12.8 Million
Previous $13.4 Million 14.99%
% of portfolio
0.45%
Previous 0.52%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025
BUY
$96.78 - $117.18 $54,874 - $66,441
567 Added 0.49%
117,001 $11.4 Million
Q3 2024

Nov 14, 2024
BUY
$106.13 - $120.89 $234,441 - $267,046
2,209 Added 1.93%
116,434 $13.4 Million
Q2 2024

Jul 31, 2024
BUY
$92.57 - $107.37 $181,437 - $210,445
1,960 Added 1.75%
114,225 $12.2 Million
Q1 2024

May 13, 2024
BUY
$95.27 - $108.47 $90,220 - $102,721
947 Added 0.85%
112,265 $10.9 Million
Q4 2023

Jan 29, 2024
BUY
$92.27 - $101.54 $217,480 - $239,329
2,357 Added 2.16%
111,318 $11.2 Million
Q3 2023

Nov 02, 2023
BUY
$94.73 - $105.13 $134,800 - $149,599
1,423 Added 1.32%
108,961 $11.1 Million
Q2 2023

Jul 27, 2023
BUY
$92.52 - $104.91 $139,890 - $158,623
1,512 Added 1.43%
107,538 $10.9 Million
Q1 2023

May 09, 2023
BUY
$80.03 - $92.81 $33,612 - $38,980
420 Added 0.4%
106,026 $9.75 Million
Q4 2022

Jan 31, 2023
SELL
$75.55 - $92.52 $142,034 - $173,937
-1,880 Reduced 1.75%
105,606 $9.58 Million
Q3 2022

Oct 21, 2022
SELL
$74.61 - $87.26 $69,536 - $81,326
-932 Reduced 0.86%
107,486 $8.17 Million
Q2 2022

Aug 11, 2022
BUY
$80.52 - $93.75 $267,326 - $311,250
3,320 Added 3.16%
108,418 $9.17 Million
Q1 2022

May 09, 2022
BUY
$80.11 - $90.62 $557,645 - $630,805
6,961 Added 7.09%
105,098 $9.22 Million
Q4 2021

Feb 11, 2022
SELL
$79.7 - $88.13 $47,899 - $52,966
-601 Reduced 0.61%
98,137 $8.58 Million
Q3 2021

Oct 27, 2021
SELL
$81.78 - $95.14 $61,498 - $71,545
-752 Reduced 0.76%
98,738 $8.08 Million
Q2 2021

Aug 03, 2021
BUY
$85.24 - $94.15 $36,908 - $40,766
433 Added 0.44%
99,490 $9.08 Million
Q1 2021

Apr 21, 2021
BUY
$83.5 - $98.47 $1.43 Million - $1.69 Million
17,177 Added 20.98%
99,057 $8.47 Million
Q4 2020

Jan 27, 2021
SELL
$78.07 - $94.43 $154,578 - $186,971
-1,980 Reduced 2.36%
81,880 $7.73 Million
Q3 2020

Oct 21, 2020
BUY
$82.14 - $91.0 $105,549 - $116,935
1,285 Added 1.56%
83,860 $7.29 Million
Q2 2020

Jul 31, 2020
BUY
$80.93 - $91.1 $281,231 - $316,572
3,475 Added 4.39%
82,575 $7.21 Million
Q1 2020

Apr 22, 2020
BUY
$70.67 - $99.01 $189,960 - $266,138
2,688 Added 3.52%
79,100 $6.52 Million
Q4 2019

Jan 15, 2020
BUY
$84.35 - $95.37 $813,134 - $919,366
9,640 Added 14.44%
76,412 $7.24 Million
Q3 2019

Oct 16, 2019
SELL
$85.54 - $94.26 $98,798 - $108,870
-1,155 Reduced 1.7%
66,772 $5.8 Million
Q2 2019

Jul 11, 2019
SELL
$75.4 - $92.8 $17,191 - $21,158
-228 Reduced 0.33%
67,927 $6.2 Million
Q1 2019

Apr 11, 2019
SELL
$75.32 - $86.15 $353,853 - $404,732
-4,698 Reduced 6.45%
68,155 $6.55 Million
Q4 2018

Jan 24, 2019
BUY
$73.66 - $82.02 $34,178 - $38,057
464 Added 0.64%
72,853 $6.25 Million
Q3 2018

Oct 24, 2018
SELL
$66.94 - $77.43 $125,847 - $145,568
-1,880 Reduced 2.53%
72,389 $6.24 Million
Q2 2018

Aug 10, 2018
SELL
$64.91 - $73.36 $144,424 - $163,226
-2,225 Reduced 2.91%
74,269 $5.61 Million
Q1 2018

Apr 17, 2018
SELL
$70.39 - $84.15 $247,491 - $295,871
-3,516 Reduced 4.39%
76,494 $6.19 Million
Q4 2017

Jan 19, 2018
SELL
$72.33 - $77.64 $19,095 - $20,496
-264 Reduced 0.33%
80,010 $6.72 Million
Q3 2017

Oct 20, 2017
BUY
$74.14 - $77.27 $5.95 Million - $6.2 Million
80,274
80,274 $6.89 Million

Others Institutions Holding NVS

# of Institutions
1,474
Shares Held
134M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $235B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Ingalls & Snyder LLC Portfolio

Follow Ingalls & Snyder LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email